does retatrutide pop up on drug test Demand for Unapproved Weight-Loss Surges Social Media Retatrutide Results: 28.3% Weight Loss

In TRIUMPH-1 the pivotal Phase 3 obesity trial, which reported topline results on May 21, 2026 participants on the highest dose lost an average of 28.3% of their body weight (70.3 lbs) at 80 weeks Evidence: Phase 3 RCT, against 2.2% on placebo

There is no standardized dose because it is compounded

However, until larger trials conclude, Mounjaro remains the proven therapy in practice

Variations in quality The quality of compounded semaglutide can vary depending on the compounding pharmacy and its practices

Your dose may need to go up as your treatment progresses, but your monthly price won't

Something went wrong, but dont fret lets give it another shot